Literature DB >> 19091631

Breast cancer by proxy: can the microenvironment be both the cause and consequence?

Lone Rønnov-Jessen1, Mina J Bissell.   

Abstract

Breast cancer is one of the most clear-cut examples of a solid tumor in which systemic cues play a decisive part in its development. The breast tissue is constantly subjected to changes in hormone levels and modifications in the microenvironment. This scenario is even more striking during tumor development because of the dramatic loss or aberration of basement membrane (BM) and myoepithelial cells and the gain of peritumoral myofibroblasts. We suggest that the microenvironment, defined here as all components of the mammary gland other than luminal and/or tumor epithelial cells, might be instrumental in maintaining organ integrity and in promoting, and at times even initiating, breast cancer development. As such, the tumor microenvironment and its constituents, alone or in combination, might serve as promising targets for therapy.

Entities:  

Mesh:

Year:  2008        PMID: 19091631      PMCID: PMC2746030          DOI: 10.1016/j.molmed.2008.11.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  79 in total

1.  Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.

Authors:  Michael J Willhauck; Nicolae Mirancea; Silvia Vosseler; Alessandra Pavesio; Petra Boukamp; Margareta M Mueller; Norbert E Fusenig; Hans-Jürgen Stark
Journal:  Carcinogenesis       Date:  2006-10-19       Impact factor: 4.944

2.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

Review 3.  A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation.

Authors:  G G Van den Eynden; C G Colpaert; A Couvelard; F Pezzella; L Y Dirix; P B Vermeulen; E A Van Marck; T Hasebe
Journal:  Histopathology       Date:  2007-06-26       Impact factor: 5.087

4.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Authors:  Antoine E Karnoub; Ajeeta B Dash; Annie P Vo; Andrew Sullivan; Mary W Brooks; George W Bell; Andrea L Richardson; Kornelia Polyak; Ross Tubo; Robert A Weinberg
Journal:  Nature       Date:  2007-10-04       Impact factor: 49.962

5.  Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.

Authors:  Laura Soucek; Elizabeth R Lawlor; Darya Soto; Ksenya Shchors; Lamorna Brown Swigart; Gerard I Evan
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

6.  Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.

Authors:  Helga Bernhard; Julia Neudorfer; Kerstin Gebhard; Heinke Conrad; Christine Hermann; Jörg Nährig; Falko Fend; Wolfgang Weber; Dirk H Busch; Christian Peschel
Journal:  Cancer Immunol Immunother       Date:  2007-07-24       Impact factor: 6.968

7.  Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.

Authors:  Koichi Fukino; Lei Shen; Attila Patocs; George L Mutter; Charis Eng
Journal:  JAMA       Date:  2007-05-16       Impact factor: 56.272

8.  Tumor-associated macrophages press the angiogenic switch in breast cancer.

Authors:  Elaine Y Lin; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

Review 9.  The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses.

Authors:  Alberto Bellini; Sabrina Mattoli
Journal:  Lab Invest       Date:  2007-07-02       Impact factor: 5.662

10.  Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.

Authors:  Carl R Walkley; Jeremy M Shea; Natalie A Sims; Louise E Purton; Stuart H Orkin
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

View more
  53 in total

Review 1.  The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.

Authors:  Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Stephanos Pavlides; Barbara Chiavarina; Gloria Bonuccelli; Trimmer Casey; Aristotelis Tsirigos; Gemma Migneco; Agnieszka Witkiewicz; Renee Balliet; Isabelle Mercier; Chengwang Wang; Neal Flomenberg; Anthony Howell; Zhao Lin; Jaime Caro; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-11-30       Impact factor: 4.534

2.  An investigation of the influence of extracellular matrix anisotropy and cell-matrix interactions on tissue architecture.

Authors:  R J Dyson; J E F Green; J P Whiteley; H M Byrne
Journal:  J Math Biol       Date:  2015-09-02       Impact factor: 2.259

3.  Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts.

Authors:  Urszula M Polanska; Ahmet Acar; Akira Orimo
Journal:  J Vis Exp       Date:  2011-10-25       Impact factor: 1.355

4.  CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

Authors:  Kavya Rakhra; Pavan Bachireddy; Tahera Zabuawala; Robert Zeiser; Liwen Xu; Andrew Kopelman; Alice C Fan; Qiwei Yang; Lior Braunstein; Erika Crosby; Sandra Ryeom; Dean W Felsher
Journal:  Cancer Cell       Date:  2010-10-28       Impact factor: 31.743

Review 5.  Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.

Authors:  Simone Buraschi; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2017-11-07       Impact factor: 11.583

6.  An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.

Authors:  Dolores Di Vizio; Matteo Morello; Federica Sotgia; Richard G Pestell; Michael R Freeman; Michael P Lisanti
Journal:  Cell Cycle       Date:  2009-08-27       Impact factor: 4.534

Review 7.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

8.  Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.

Authors:  Maria Laura Polo; Maria Victoria Arnoni; Marina Riggio; Victoria Wargon; Claudia Lanari; Virginia Novaro
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

9.  Breast tumour stroma is a prognostic indicator and target for therapy.

Authors:  Anthony Howell; Goran Landberg; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

10.  The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.

Authors:  Jodie M Fleming; Tyler C Miller; Mariam Quinones; Zhen Xiao; Xia Xu; Matthew J Meyer; Erika Ginsburg; Timothy D Veenstra; Barbara K Vonderhaar
Journal:  BMC Med       Date:  2010-05-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.